Nexus - 0504 - New Times Magazine-pages

Page Content (OCR)

Dr Sam Chachoua's INDUCED REMISSION THERAPY Dr Sam Chachoua has identified ‘nemesis organisms’ that can control and even cure diseases such as cancer and AIDS, but his therapies have been largely ignored by the medical establishment. Part 2 We published the first part of Dr Sam Chachoua's story in NEXUS 5/01 and promised to follow up with further detail on his Induced Remission Therapy. Here we present an edited transcript of the lecture he gave at the 2nd World Congress on Cancer, held in September 1995, followed by a recent update from Dr Chachoua. — Editor y name is Sam Chachoua and I'm an MD from Melbourne, Australia. What I'm going to talk to you about now is something quite new and revolutionary. It's called Induced Remission Therapy and it's a treatment that is based on three natural phenomena: organ resistance, organism resistance, and sponta- neous remission. I first got into cancer research at an early age when my father was diagnosed with mul- tiple myeloma, and I basically tried to see whether I could find something that could help him where conventional therapies were failing. One thing that I noted in all the studies I had was that there are parts of the human body—for example, the small intestine—which are consistently resistant to cancer. Regardless of how far and wide cancer usually spreads, it usually leaves the small intestine alone. There's also something known as "organism resistance", which means that most other animals that we try to give human cancer to are able to reject it. So I set about designing an experimental protocol where I was going to find out what it was about the small intes- tine that made it resistant to cancer, and I was going to find out what it was about horses, cats and dogs and other animals that made them resistant to human cancer. To cut a long story short, I managed to isolate the immunological factors which I used in experimental protocols at the Peter McCallum Cancer Institute. At age 18 I'd written my first paper, and the following year I presented it before the Clinical Oncology Society of Australia. Let me tell you, I was pretty proud of myself. I thought: "Kid, you've got it made; you've helped your dad now, and this therapy is going to be adopted soon." And I could just see it. I was going to walk into the Clinical Oncology Society of Australia. Everybody's going to cheer and get on the phone and say: "Hey, we've got a young kid here; give me the Nobel Committee." Naive! I was actually greeted with all the warmth one usually reserves for a venereal disease or an acute attack of haemorrhoids! Let me just jump to how this form of therapy can apply to AIDS. We've known for a very long time that it's impossible to give animals AIDS by injecting them with HIV. Now there are two possibilities: either animals are inherently resistant, i.e., they don't have receptor sites for HIV; or maybe, just maybe, they have an immune system which is capable of fighting and destroying the virus. Well, hey, let's check it out! So the initial data all showed promise that you could raise an immune response out of a horse, for example, that would selectively destroy HIV. What intrigued and amazed me was seeing the thought processes or, rather, not being able to see the thought processes in the AIDS researchers who for years now have tried to find some way of developing an immune system resistant to AIDS. They sit there and say: "Well, we need to make an animal model. Once we have an animal model, once we've made an animal sick with AIDS we can find a way to cure it." So they get their little test animals; they get their rats, their dogs, their horses and cats; they inject them with HIV—and they can't give them AIDS! They get really upset about that: "How am I supposed to find a cure for AIDS if I can't give this animal AIDS? I'm injecting it with HIV to try to find an immune response that will kill HIV, and it won't take it. How am I supposed to do my job?" Are you fol- lowing the thought pattern here? It's looking right at them. From a lecture presented by Sam Chachoua, MB, BS on "Revolutionary New Therapies in the Treatment of Incurable Diseases" at the 2nd World Congress on Cancer Sydney, Australia 15-19 September 1995 JUNE - JULY 1998 NEXUS -35